D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 106 Citations 35,032 408 World Ranking 3872 National Ranking 2199

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Radiology

The scientist’s investigation covers issues in Positron emission tomography, Nuclear medicine, Radiology, Internal medicine and Cancer. His work carried out in the field of Positron emission tomography brings together such families of science as Clinical trial, Cervix, Rectum, Esophageal cancer and Recurrent Colorectal Carcinoma. Barry A. Siegel combines subjects such as Cervical cancer, Carcinoma, Radiation therapy and Lymph node with his study of Nuclear medicine.

His studies deal with areas such as Prospective cohort study, Lung cancer, Metastasis and Adenocarcinoma as well as Radiology. The concepts of his Internal medicine study are interwoven with issues in Standardized uptake value and Oncology. As a member of one scientific family, he mostly works in the field of Cancer, focusing on Gastroenterology and, on occasion, Adverse effect.

His most cited work include:

  • Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma (1095 citations)
  • Recommendations on the Use of 18F-FDG PET in Oncology (756 citations)
  • Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials (597 citations)

What are the main themes of his work throughout his whole career to date?

Barry A. Siegel mainly investigates Radiology, Nuclear medicine, Positron emission tomography, Internal medicine and Oncology. His work in the fields of Radiology, such as PET-CT, intersects with other areas such as In patient. His Nuclear medicine research includes themes of Magnetic resonance imaging, Prospective cohort study, Lung cancer and Radiation therapy.

His research integrates issues of Colorectal cancer, Carcinoma and Primary tumor, Metastasis in his study of Positron emission tomography. In his research, Platelet is intimately related to Pathology, which falls under the overarching field of Internal medicine. His work deals with themes such as Stage, Lymph node and Cervix, which intersect with Cervical cancer.

He most often published in these fields:

  • Radiology (38.77%)
  • Nuclear medicine (34.57%)
  • Positron emission tomography (28.15%)

What were the highlights of his more recent work (between 2015-2021)?

  • Radiology (38.77%)
  • Positron emission tomography (28.15%)
  • PET-CT (8.40%)

In recent papers he was focusing on the following fields of study:

Barry A. Siegel focuses on Radiology, Positron emission tomography, PET-CT, Prostate cancer and Internal medicine. His Radiology research is multidisciplinary, relying on both Cervical cancer, Cancer, Lung cancer and Disease. His Positron emission tomography study is focused on Nuclear medicine in general.

His Nuclear medicine study combines topics from a wide range of disciplines, such as Clinical trial, Cohort and Primary tumor. The study incorporates disciplines such as Prostate and Radiation therapy in addition to Prostate cancer. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Oncology.

Between 2015 and 2021, his most popular works were:

  • 64Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer (134 citations)
  • Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia. (126 citations)
  • Single-agent Ibrutinib in Relapsed or Refractory Follicular Lymphoma: A Phase 2 Consortium Trial (74 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

Barry A. Siegel spends much of his time researching Internal medicine, Nuclear medicine, Oncology, Radiology and PET-CT. His biological study spans a wide range of topics, including Gastroenterology and Standardized uptake value. His Nuclear medicine research incorporates elements of Prostatectomy, Clinical trial, Lymphadenectomy, Lymph node and Multicenter trial.

The various areas that Barry A. Siegel examines in his Radiology study include Cancer, Prostate cancer and Lung cancer. PET-CT is a primary field of his research addressed under Positron emission tomography. Positron emission tomography is frequently linked to Pathology in his study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

Malik E. Juweid;Sigrid Stroobants;Otto S. Hoekstra;Felix M. Mottaghy.
Journal of Clinical Oncology (2007)

1585 Citations

Recommendations on the Use of 18F-FDG PET in Oncology

James W. Fletcher;James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel.
The Journal of Nuclear Medicine (2008)

1169 Citations

Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0

Dominique Delbeke;R. Edward Coleman;Milton J. Guiberteau;Manuel L. Brown.
The Journal of Nuclear Medicine (2006)

800 Citations

Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials

Lalitha K. Shankar;John M. Hoffman;Steve Bacharach;Michael M. Graham.
The Journal of Nuclear Medicine (2006)

777 Citations

Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher.
Clinical Cancer Research (2005)

760 Citations

Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.

Jeffrey Bradley;Wade L. Thorstad;Sasa Mutic;Tom R. Miller.
International Journal of Radiation Oncology Biology Physics (2004)

729 Citations

Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).

Felix G. Fernandez;Jeffrey A. Drebin;David C. Linehan;Farrokh Dehdashti.
Annals of Surgery (2004)

726 Citations

Lymph Node Staging by Positron Emission Tomography in Patients With Carcinoma of the Cervix

Perry W. Grigsby;Barry A. Siegel;Farrokh Dehdashti.
Journal of Clinical Oncology (2001)

535 Citations

Breast cancer: PET imaging of estrogen receptors.

M A Mintun;M J Welch;B A Siegel;C J Mathias.
Radiology (1988)

494 Citations

Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry

Bruce E. Hillner;Barry A. Siegel;Dawei Liu;Anthony F. Shields.
Journal of Clinical Oncology (2008)

487 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Barry A. Siegel

Michael J. Welch

Michael J. Welch

Washington University in St. Louis

Publications: 106

David A. Mankoff

David A. Mankoff

University of Pennsylvania

Publications: 100

Rodney J. Hicks

Rodney J. Hicks

Peter MacCallum Cancer Centre

Publications: 88

Abass Alavi

Abass Alavi

University of Pennsylvania

Publications: 88

Wim J.G. Oyen

Wim J.G. Oyen

Humanitas University

Publications: 77

Richard L. Wahl

Richard L. Wahl

Washington University in St. Louis

Publications: 77

Jason S. Lewis

Jason S. Lewis

Memorial Sloan Kettering Cancer Center

Publications: 74

Ronald Boellaard

Ronald Boellaard

Amsterdam UMC

Publications: 70

Perry W. Grigsby

Perry W. Grigsby

Washington University in St. Louis

Publications: 62

Steven M. Larson

Steven M. Larson

Memorial Sloan Kettering Cancer Center

Publications: 62

Johannes Czernin

Johannes Czernin

University of California, Los Angeles

Publications: 62

Stefano Fanti

Stefano Fanti

University of Bologna

Publications: 59

Heiko Schöder

Heiko Schöder

Memorial Sloan Kettering Cancer Center

Publications: 59

Ken Herrmann

Ken Herrmann

University of Duisburg-Essen

Publications: 54

Sanjiv S. Gambhir

Sanjiv S. Gambhir

Stanford University

Publications: 50

Homer A. Macapinlac

Homer A. Macapinlac

The University of Texas MD Anderson Cancer Center

Publications: 49

Trending Scientists

G. Cornelis van Kooten

G. Cornelis van Kooten

University of Victoria

John Paisley

John Paisley

Columbia University

Ye Tao

Ye Tao

National Research Council Canada

Ole Hindsgaul

Ole Hindsgaul

University of Alberta

Piotr Stepnowski

Piotr Stepnowski

University of Gdańsk

S. R. P. Silva

S. R. P. Silva

University of Surrey

Eitan Bibi

Eitan Bibi

Weizmann Institute of Science

Joaquim Ruiz

Joaquim Ruiz

Scientific University of the South

Panagiotis Karkanas

Panagiotis Karkanas

American School of Classical Studies at Athens

Ming Xue

Ming Xue

University of Oklahoma

Luca Stabile

Luca Stabile

University of Cassino and Southern Lazio

Remko Uijlenhoet

Remko Uijlenhoet

Delft University of Technology

Adriano Mari

Adriano Mari

National Health Service

Luise Poustka

Luise Poustka

University of Göttingen

Kenneth H. Brown

Kenneth H. Brown

University of California, Davis

Jean Logan

Jean Logan

New York University

Something went wrong. Please try again later.